EE02974B1 - Bisfenüülalküülpiperasiinide kasutamine narkomaaniavastase ravimi valmistamiseks - Google Patents

Bisfenüülalküülpiperasiinide kasutamine narkomaaniavastase ravimi valmistamiseks

Info

Publication number
EE02974B1
EE02974B1 EE9400398A EE9400398A EE02974B1 EE 02974 B1 EE02974 B1 EE 02974B1 EE 9400398 A EE9400398 A EE 9400398A EE 9400398 A EE9400398 A EE 9400398A EE 02974 B1 EE02974 B1 EE 02974B1
Authority
EE
Estonia
Prior art keywords
pct
drug
abuse
sec
substance
Prior art date
Application number
EE9400398A
Other languages
English (en)
Estonian (et)
Inventor
Bj�rk Anders
Andersson Gunnar
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of EE02974B1 publication Critical patent/EE02974B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
EE9400398A 1992-04-21 1994-11-17 Bisfenüülalküülpiperasiinide kasutamine narkomaaniavastase ravimi valmistamiseks EE02974B1 (et)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201239A SE9201239D0 (sv) 1992-04-21 1992-04-21 Agents for treating substance abuse disorders

Publications (1)

Publication Number Publication Date
EE02974B1 true EE02974B1 (et) 1997-04-15

Family

ID=20386004

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9400398A EE02974B1 (et) 1992-04-21 1994-11-17 Bisfenüülalküülpiperasiinide kasutamine narkomaaniavastase ravimi valmistamiseks

Country Status (26)

Country Link
US (1) US5565455A (xx)
EP (1) EP0637242B1 (xx)
JP (1) JP3245642B2 (xx)
KR (1) KR100321319B1 (xx)
AT (1) ATE184484T1 (xx)
AU (1) AU659941B2 (xx)
BG (1) BG62154B1 (xx)
BR (1) BR9306361A (xx)
CA (1) CA2118512C (xx)
CZ (1) CZ281296B6 (xx)
DE (1) DE69326459T2 (xx)
DK (1) DK0637242T3 (xx)
EE (1) EE02974B1 (xx)
ES (1) ES2139007T3 (xx)
GR (1) GR3032030T3 (xx)
HU (1) HU223463B1 (xx)
IL (1) IL105449A (xx)
NO (2) NO308827B1 (xx)
PH (1) PH31051A (xx)
RO (1) RO117150B1 (xx)
RU (1) RU2126254C1 (xx)
SE (1) SE9201239D0 (xx)
SK (1) SK279940B6 (xx)
UA (1) UA27884C2 (xx)
WO (1) WO1993020821A1 (xx)
ZA (1) ZA932757B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
SE9201956D0 (sv) * 1992-06-25 1992-06-25 Kabi Pharmacia Ab Novel nicotinicacid esters
SE9601708D0 (sv) * 1996-05-06 1996-05-06 Pharmacia Ab Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders
HU226859B1 (en) 1997-10-27 2009-12-28 Neurosearch As Phenyl- or heteroaryl-homopiperazines, their use and medicaments containing them
US6632823B1 (en) * 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6090780A (en) * 1999-04-07 2000-07-18 Chandon Prasad Histidyl-proline diketopiperazine and method of use
EP2422772A3 (en) 2002-09-20 2012-04-18 Alpharma, Inc. Sequestering subunit and related compositions and methods
HUE032156T2 (en) 2006-06-19 2017-09-28 Alpharma Pharmaceuticals Llc Pharmaceutical preparations
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
BRPI1003506B1 (pt) 2010-09-24 2019-12-03 Ache Int Bvi Ltd composto alquil-piperazino-fenil-4(3h)quinazolinonas e uso do composto alquil-piperazino-fenil-4(3h)quinazolinonas associado aos receptores serotoninérgicos 5-ht1a e 5-ht2a

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2958694A (en) * 1959-06-22 1960-11-01 Janssen Paul Adriaan Jan 1-(aroylalkyl)-4-(2'-pyridyl) piperazines
US2985657A (en) * 1959-10-12 1961-05-23 Paul A J Janssen 1-(aroylalkyl)-4-heterocyclylpiperazines
US2979508A (en) * 1959-10-12 1961-04-11 Paul A J Janssen Heterocyclic derivatives of 1-phenyl-omega-(piperazine) alkanols
NO154582C (no) * 1978-10-20 1986-11-05 Ferrosan Ab Analogifremgangsmaate for fremstilling av terapeutisk aktive difenyl-dibutylpiperazinkarboksamider.
US4605655A (en) * 1984-03-06 1986-08-12 Bristol-Myers Company Antipsychotic 1-fluorophenylbutyl-4-(2-pyrimidinyl)piperazine derivatives
US4766215A (en) * 1987-02-27 1988-08-23 American Home Products Corporation Histamine H1 -receptor antagonists
SE8701375D0 (sv) * 1987-04-02 1987-04-02 Leo Ab Novel pyridyl- and pyrimidyl derivatives
US5217987A (en) * 1989-10-30 1993-06-08 Berger Stephen P Dopamine uptake inhibitors in reducing substance abuse and/or craving
SE9100860D0 (sv) * 1991-03-22 1991-03-22 Kabi Pharmacia Ab New use

Also Published As

Publication number Publication date
AU659941B2 (en) 1995-06-01
NO20004169D0 (no) 2000-08-21
SK279940B6 (sk) 1999-06-11
EP0637242A1 (en) 1995-02-08
IL105449A (en) 1998-02-22
SK126994A3 (en) 1995-07-11
DK0637242T3 (da) 2000-03-27
DE69326459T2 (de) 2000-03-23
ATE184484T1 (de) 1999-10-15
HU223463B1 (hu) 2004-07-28
WO1993020821A1 (en) 1993-10-28
RO117150B1 (ro) 2001-11-30
NO318461B1 (no) 2005-03-21
CA2118512C (en) 2004-07-27
ES2139007T3 (es) 2000-02-01
SE9201239D0 (sv) 1992-04-21
NO20004169L (no) 1994-10-20
BR9306361A (pt) 1998-06-30
NO308827B1 (no) 2000-11-06
RU94045866A (ru) 1996-10-20
KR950701221A (ko) 1995-03-23
KR100321319B1 (ko) 2002-07-27
RU2126254C1 (ru) 1999-02-20
UA27884C2 (uk) 2000-10-16
NO943977L (no) 1994-10-20
CZ281296B6 (cs) 1996-08-14
AU4043793A (en) 1993-11-18
NO943977D0 (no) 1994-10-20
JP3245642B2 (ja) 2002-01-15
HUT71420A (en) 1995-11-28
ZA932757B (en) 1993-10-28
BG62154B1 (bg) 1999-04-30
HU9403020D0 (en) 1994-12-28
EP0637242B1 (en) 1999-09-15
PH31051A (en) 1998-02-03
CA2118512A1 (en) 1993-10-28
CZ260694A3 (en) 1995-09-13
DE69326459D1 (de) 1999-10-21
BG99129A (bg) 1995-08-28
US5565455A (en) 1996-10-15
IL105449A0 (en) 1993-08-18
GR3032030T3 (en) 2000-03-31
JPH08503449A (ja) 1996-04-16

Similar Documents

Publication Publication Date Title
EE02974B1 (et) Bisfenüülalküülpiperasiinide kasutamine narkomaaniavastase ravimi valmistamiseks
DK0538422T3 (da) Hidtil ukendt anvendelse af diphenylbutyl-piperazincarboxamider til behandling af stofmisbrugslidelser
DE69613113T2 (de) Unhabhängige vorrichtung zur transdermalen verabreichung von medikamenten
DE69132688T2 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
FI964332A0 (fi) Eräiden metaanibisfosfonihappojohdannaisten käyttö proteesin löystymisen ja proteesin vaelluksen estämiseen
DE69617729D1 (de) Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
DE3778008D1 (de) Ketonderivate als arzneimittel zur behandlung oder vorbeugung des entzugssyndromes.
NO943293L (no) Anvendelse av et medikament ved avvenning mot röyk
FI945446A0 (fi) Kotiinin käyttö tupakan vieroitusoireyhtymän lievittämiseksi
Matalon et al. Chronic use of hypnotics in a family practice—patients' reluctance to stop treatment
KR890011572A (ko) 정신 기능을 증진시키는 방법
DE69307705T2 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4,-triazinisethionat zur behandlung und vorbeugung von drogenabhaengigkeit,-toleranz und- sensibilisierung
Goswami et al. Pentazocine Detoxification: A Focus on Clonidine
Jeanmonod et al. The drug dependent prisoner: Medical treatment and its limits
KR910005868A (ko) 신규 치료법
MX9703032A (es) Nuevas aplicaciones del 5-etoxicarbonil-2,4,6-trimetil-1,4-dihidropiridina-3-carboxi lato de 2-[n-(1,2-benzisotiazolil-3(2h) ona-1,1-dioxido]etilo.
TH19281A (th) การรักษาความกระหายนิโคทีน และ/หรืออาการโรคเนื่องจากการถอนยาจากการสูบบุหรี่

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

MM4A Lapsed by not paying the annual fees

Effective date: 20091117